Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Erlotinib

Paronychia due to Pseudomonas aeruginosa in an elderly patient: case report

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Thellier S, Wierzbicka-Hainaut E, Guillet G.Epidermal growth factor receptor inhibitor: which treatment when topical therapy failed? Nouvelles Dermatologiques 28: 171-172, No. 3, Part 1, Mar 2009 - France

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Erlotinib. React. Wkly. 1305, 15 (2010). https://doi.org/10.2165/00128415-201013050-00046

    Download citation

    Keywords

    • Public Health
    • Pseudomonas Aeruginosa
    • Erlotinib
    • Paronychia